Restart Life Sciences Corp.
HEAL.CN
Price:
$0.12
Market Cap:
$4.39M
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Industry
Biotechnology
IPO Date
2006-09-22
Stock Exchange
CNQ
Ticker
HEAL.CN
PE Ratio
[-12.00]
ROE
[404.52%]
Current Ratio
[1.25]
Dividend Yield
[0%]
Enterprise Value
[4.22M]
Dividend History
The ROE as of December 2025 (TTM) for Restart Life Sciences Corp. (HEAL.CN) is 404.52%
According to Restart Life Sciences Corp.’s latest financial reports and current stock price. The company's current ROE is 404.52%. This represents a change of -327.64% compared to the average of -177.70% of the last 4 quarters.
Restart Life Sciences Corp. (HEAL.CN) Historical ROE (quarterly & annually)
How has HEAL.CN ROE performed in the past?
The mean historical ROE of Restart Life Sciences Corp. over the last ten years is -1134.87%. The current 404.52% ROE has changed -135.64% with respect to the historical average. Over the past ten years (40 quarters), HEAL.CN's ROE was at its highest in in the September 2015 quarter at 1.08%. The ROE was at its lowest in in the December 2022 quarter at -5989.83%.
Average
-1134.87%
Median
-196.37%
Minimum
-9096.56%
Maximum
151.05%
Restart Life Sciences Corp. (HEAL.CN) ROE by Quarter and Year
Discovering the peaks and valleys of Restart Life Sciences Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.14%
Maximum Annual ROE = 151.05%
Minimum Annual Increase = -149.75%
Minimum Annual ROE = -9096.56%
| Year | ROE | Change |
|---|---|---|
| 2024 | -75.15% | -149.75% |
| 2023 | 151.05% | -101.66% |
| 2022 | -9096.56% | 1.46% |
| 2021 | -584.75% | -38.27% |
| 2020 | -947.35% | 4.14% |
| 2019 | -22.33% | -54.73% |
| 2018 | -49.34% | -18.93% |
| 2017 | -60.86% | -80.84% |
| 2016 | -317.59% | -8.16% |
| 2015 | -345.80% | -78.73% |
Restart Life Sciences Corp. (HEAL.CN) Average ROE
How has HEAL.CN ROE performed in the past?
The current ROE of Restart Life Sciences Corp. (HEAL.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3006.89%
5-year avg
-2110.55%
10-year avg
-1134.87%
Restart Life Sciences Corp. (HEAL.CN) ROE vs. Peers
How is HEAL.CN’s ROE compared to its peers?
Restart Life Sciences Corp.’s ROE is greater than XORTX Therapeutics Inc. (-73.46%), less than Appili Therapeutics Inc. (16.72%), greater than Algernon Pharmaceuticals Inc. (-98.85%), less than TILT Holdings Inc. (218.06%), greater than CordovaCann Corp. (-332.38%), less than City View Green Holdings Inc. (27.62%), greater than Doseology Sciences Inc. (-34.11%), less than Kane Biotech Inc. (211.08%), greater than Revive Therapeutics Ltd. (-60.77%), less than Aptose Biosciences Inc. (123.88%),
| Company | ROE | Market cap |
|---|---|---|
| -73.46% | $3.22M | |
| 16.72% | $3.03M | |
| -98.85% | $2.91M | |
| 218.06% | $3.47M | |
| -332.38% | $4.11M | |
| 27.62% | $3.43M | |
| -34.11% | $3.33M | |
| 211.08% | $4.99M | |
| -60.77% | $6.48M | |
| 123.88% | $5.77M |
Build a custom stock screener for Restart Life Sciences Corp. (HEAL.CN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Restart Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Restart Life Sciences Corp. (HEAL.CN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Restart Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Restart Life Sciences Corp.'s ROE?
How is the ROE calculated for Restart Life Sciences Corp. (HEAL.CN)?
What is the highest ROE for Restart Life Sciences Corp. (HEAL.CN)?
What is the 3-year average ROE for Restart Life Sciences Corp. (HEAL.CN)?
What is the 5-year average ROE for Restart Life Sciences Corp. (HEAL.CN)?
How does the current ROE for Restart Life Sciences Corp. (HEAL.CN) compare to its historical average?